Welcome to LookChem.com Sign In|Join Free
  • or
(4E)-4-(1-benzofuran-2-ylmethylene)-2-phenyl-1,3-oxazol-5(4H)-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1152257-29-8

Post Buying Request

1152257-29-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1152257-29-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1152257-29-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,2,2,5 and 7 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1152257-29:
(9*1)+(8*1)+(7*5)+(6*2)+(5*2)+(4*5)+(3*7)+(2*2)+(1*9)=128
128 % 10 = 8
So 1152257-29-8 is a valid CAS Registry Number.

1152257-29-8Relevant academic research and scientific papers

Reaction of substituted furan-2-carboxaldehydes and furo[b]pyrrole type aldehydes with hippuric acid

Puterova, Zita,Sterk, Heinz,Krutosikova, Alzbeta

, p. 11 - 21 (2004)

4-Heteroarylidene-2-phenyl-1,3-oxazol-5(4H)-ones were prepared by reactions of hippuric acid with substituted furan-2-carboxaldehydes or furo[b]pyrrole type aldehydes. The reactivity of various furan-2-carboxaldehyde derivatives in this reaction is discussed. The effect of microwave irradiation on some condensation reactions was compared with "classical" conditions. The results show that microwave irradiation shortens the reaction times while affording comparable yields. Elementary analysis, UV, IR and 1D NMR proved the structure of new synthesised compounds. 2D NMR spectroscopic measurements confirmed that the configuration at the carbon-carbon double bond corresponds to the pure E isomers of the products.

Novel peptide mimetic inhibitors of hepatitis C serine protease derived from isomannide

Barros, Thalita G.,Pinheiro, Sergio,Williamson, John S.,Tanuri, Amilcar,Pereira, Helena S.,Brindeiro, Rodrigo M.,Neto, Jose B. A.,Antunes, Octavio A. C.,Muri, Estela M. F.

scheme or table, p. 620 - 626 (2009/06/28)

Hepatitis C (HCV) infection is a cause of chronic liver disease such as cirrhosis, carcinoma, or liver failure, and the current therapy is effective in only 50% of patients. Serine proteases, which are present in HCV, are the most studied class of proteolytic enzymes, and are a primary target in the drug development field. In this paper, we describe the synthesis and biological studies of a novel class of peptide mimetic compounds as potential HCV serine protease inhibitors. Georg Thieme Verlag Stuttgart.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1152257-29-8